Baxter AG; est. no. 0258

Baxter AG - Vienna, Austria and Bohumil, Czech Republic; A subsidiary of Baxter Hyland Immuno. Originally Oesterreichisches Institut fuer Haemoderivate GmbH (OIH; Austrian Institute for Hemoderivatives), which became part of Immuno Intl. in 1960. Immuno AG was acquired by Baxter in 1997, and was renamed Baxter AG

Related product monographs:

1. Factor VIII, rDNA, PFM -- Manuf. other
2. Factor VIII, porcine rDNA -- Parent co.
3. Influenza vaccine, H1N1, Vero cells/Baxter -- Manuf. ; R&D ; Tech.
4. influenza vaccine, H5N1/Baxter -- Manuf. ; R&D ; Tech. ; World mark.
5. Anistreplase -- Manuf. other
6. Lys-Plasminogen, conc. -- Manuf. ; Tech. ; Former
7. Anti-Inhibitor Coagulant/Baxter -- R&D ; Tech.
8. Factor IX VH -- Manuf. ; R&D ; Tech. ; Former
9. Fibrin Sealant/Tisseel -- Manuf. ; R&D ; Tech.
10. Fibrin Sealant/Haemacure -- Manuf. ; R&D ; Tech. ; Former
11. Immune Globulin (IGIV)/Baxter -- Manuf. other ; R&D ; Tech.
12. Protein C, plasma-derived -- Manuf. ; R&D ; Tech. ; Intl. mark.

Location - Vienna A-1220 Austria For

Further information:
Description, ordering information, etc.
Order/Inquiry
Products Database

Copyright ©2020. Biotechnology Information Institute